Published by Josh White on 25th July 2019
(Sharecast News) - Hikma Pharmaceuticals announced the signing of an exclusive license agreement to commercialise cariprazine - a novel antipsychotic - in certain Middle East and North Africa (MENA) markets on Thursday.
URL: http://www.digitallook.com/dl/news/story/29346568/...